May 27, 2021

Unlocking Complete Cannabis Experience with Extract Technology | Sproutly Canada

Midas Letter
Midas Letter
Unlocking Complete Cannabis Experience with Extract Technology | Sproutly Canada

Sproutly Canada Inc (OTCMKTS:SRUTFCNSX:SPR) has undergone a complete business transformation in recent times. Sproutly has stopped cultivation altogether and focused completely on its proprietary extract technology and cannabis 2.0 products.

Cultivators of flower products in Canada continue to stock more goods than they’re able to sell. It is, therefore, harder to differentiate yourself as a company by developing unique properties within different cannabis strains. This abundance of high-quality flowers has shifted Sproutly’s goals. The now 100% focused extract company can concentrate on using their natural water-soluble plant extract and natural oil extract technology to produce differentiated edibles and beverages.

“We make sure our products taste, smell, and feel like what they should be. I do not consider this to be a cannabis shot, I consider this a shot that’s capable of delivering a cannabis experience” – Sproutly Canada CEO Dr. Arup Sen talking about the company’s new 2Oz cannabis shots

The unique aspect of Sproutlys APP extraction technology is its ability to maintain a complete flower profile after extraction. Sproutly’s products will actually reflect the natural effects of the strain, rather than just the THC, CBD, and CPG compounds. This allows Sproutly to maintain the effects of total relaxation, creativity, and euphoria of people’s favourite strains within their beverages or gummies.

Watch the full interview for an overview of Sproutly’s new business plan, launching their latest products and the cannabis 2.0 competitive landscape.

Related Articles


Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.